R. Aller

7.7k total citations
338 papers, 4.9k citations indexed

About

R. Aller is a scholar working on Physiology, Epidemiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, R. Aller has authored 338 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 170 papers in Physiology, 113 papers in Epidemiology and 92 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in R. Aller's work include Diet and metabolism studies (78 papers), Adipose Tissue and Metabolism (76 papers) and Adipokines, Inflammation, and Metabolic Diseases (66 papers). R. Aller is often cited by papers focused on Diet and metabolism studies (78 papers), Adipose Tissue and Metabolism (76 papers) and Adipokines, Inflammation, and Metabolic Diseases (66 papers). R. Aller collaborates with scholars based in Spain, Czechia and Italy. R. Aller's co-authors include Daniel Antonio de Luis, Olatz Izaola, M. González Sagrado, R. Conde, David Primo, L Cuéllar, Beatriz de la Fuente, M C Terroba, E. Romero and David Pacheco and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Diabetes Care.

In The Last Decade

R. Aller

332 papers receiving 4.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Aller Spain 34 2.1k 1.6k 1.3k 1.0k 718 338 4.9k
Olatz Izaola Spain 35 2.5k 1.2× 1.4k 0.9× 1.3k 1.0× 999 1.0× 738 1.0× 332 4.9k
Bruno Geloneze Brazil 33 1.7k 0.8× 946 0.6× 1.5k 1.2× 1.4k 1.4× 509 0.7× 125 4.8k
Teri L. Hernandez United States 34 1.2k 0.5× 1.1k 0.7× 1.1k 0.9× 1.1k 1.0× 836 1.2× 87 5.3k
Barbara M. Retzlaff United States 25 1.5k 0.7× 1.7k 1.1× 1.3k 1.1× 754 0.7× 474 0.7× 42 4.2k
Bettina Mittendorfer United States 47 3.9k 1.8× 2.2k 1.4× 2.1k 1.7× 1.1k 1.1× 1.4k 2.0× 129 7.6k
T. M. Wallace United Kingdom 14 1.7k 0.8× 1.3k 0.8× 2.5k 2.0× 1.2k 1.1× 994 1.4× 18 6.1k
Jean‐Philippe Bastard France 35 2.3k 1.1× 3.0k 1.9× 1.1k 0.9× 621 0.6× 1.4k 2.0× 100 7.0k
Robert N. Cooney United States 37 1.6k 0.7× 916 0.6× 619 0.5× 1.4k 1.3× 1.0k 1.4× 117 5.3k
Susanne Kaser Austria 37 1.3k 0.6× 2.2k 1.4× 869 0.7× 849 0.8× 808 1.1× 104 4.8k
Priya Mohanty United States 33 1.9k 0.9× 2.6k 1.6× 2.4k 1.9× 759 0.7× 1.5k 2.1× 45 7.3k

Countries citing papers authored by R. Aller

Since Specialization
Citations

This map shows the geographic impact of R. Aller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Aller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Aller more than expected).

Fields of papers citing papers by R. Aller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Aller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Aller. The network helps show where R. Aller may publish in the future.

Co-authorship network of co-authors of R. Aller

This figure shows the co-authorship network connecting the top 25 collaborators of R. Aller. A scholar is included among the top collaborators of R. Aller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Aller. R. Aller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Romero‐Gómez, Manuel, Javier Escalada, Jesús Carretero, et al.. (2025). Guía de práctica clínica multidisciplinar de manejo de la esteatosis hepática metabólica. Gastroenterología y Hepatología. 48(8). 502442–502442. 2 indexed citations
2.
Iruzubieta, Paula, Rebeca Mayo, Itziar Mincholé, et al.. (2024). One‐step non‐invasive diagnosis of metabolic dysfunction‐associated steatohepatitis and fibrosis in high‐risk population. United European Gastroenterology Journal. 12(7). 919–929. 8 indexed citations
3.
Múñoz‐Hernández, Rocío, Antonio Gil‐Gómez, R. Aller, et al.. (2023). Role of EpCAM+ CD133+ extracellular vesicles in steatosis to steatohepatitis transition in NAFLD. Liver International. 43(9). 1909–1919. 5 indexed citations
4.
Romero‐Gómez, Manuel, R. Aller, Javier Ampuero, et al.. (2023). AEEH "Consensus about detection and referral of hidden prevalent liver diseases". Gastroenterología y Hepatología (English Edition). 46(3). 236–247. 2 indexed citations
5.
Luis, Daniel Antonio de, David Primo, Olatz Izaola, & R. Aller. (2022). Papel del polimorfismo del gen de la resistina (rs7139228) en la respuesta metabólica tras una dieta mediterránea hipocalórica. Endocrinología Diabetes y Nutrición. 70(2). 88–97.
6.
Tamayo-Velasco, Álvaro, E. Alvarez, Hugo Gonzalo‐Benito, et al.. (2021). Evaluation of Cytokines as Robust Diagnostic Biomarkers for COVID-19 Detection. Journal of Personalized Medicine. 11(7). 681–681. 15 indexed citations
7.
Luis, Daniel Antonio de, David Primo, Olatz Izaola, & R. Aller. (2020). Effect of two different dietary fatty acid profiles and variant rs266729 in ADIPOQ on weight loss and adiponectin concentrations. Endocrinología Diabetes y Nutrición (English ed ). 67(6). 374–382. 1 indexed citations
8.
Luis, Daniel Antonio de, Olatz Izaola, David Primo, et al.. (2018). The association of SNP276G>T at adiponectin gene with insulin resistance and circulating adiponectin in response to two different hypocaloric diets. Diabetes Research and Clinical Practice. 137. 93–99. 10 indexed citations
9.
Luis, Daniel Antonio de, R. Aller, Olatz Izaola, & Enrique Romero. (2016). Effect of -55CT Polymorphism of UCP3 on Insulin Resistance and Cardiovascular Risk Factors after a High Protein/Low Carbohydrate versus a Standard Hypocaloric Diet. Annals of Nutrition and Metabolism. 68(3). 157–163. 19 indexed citations
10.
Aller, R., et al.. (2015). Effect of silymarin plus vitamin E in patients with non-alcoholic fatty liver disease. A randomized clinical pilot study.. PubMed. 19(16). 3118–24. 95 indexed citations
11.
Jiménez‐Sousa, María Ángeles, Raquel Almansa, A. Caro-Patón, et al.. (2011). Perfiles de expresión génica en las primeras doce semanas de tratamiento en pacientes con hepatitis C crónica. Enfermedades Infecciosas y Microbiología Clínica. 29(8). 573–580. 4 indexed citations
12.
Luis, Daniel Antonio de, R. Aller, Olatz Izaola, M. González Sagrado, & R. Conde. (2011). FRECUENCIA ALÉLICA DEL POLIMORFISMO G308A DEL FACTOR DE NECROSIS TUMORAL ALPHA Y RELACIÓN CON FACTORES DE RIESGO CARDIOVASCULAR Y ADIPOCITOQUINAS EN PACIENTES OBESOS. Nutrición Hospitalaria. 26. 1 indexed citations
13.
Luis, Daniel Antonio de, R. Aller, & Juan Bustamante. (2008). Aspectos terapéuticos de la dieta en la hipertensión arterial. 1(1). 0. 4 indexed citations
14.
Luis, Daniel Antonio de, Olatz Izaola, Luis Cuéllar, et al.. (2006). Nutritional Assessment: Predictive Variables at Hospital Admission Related with Length of Stay. Annals of Nutrition and Metabolism. 50(4). 394–398. 44 indexed citations
15.
Luis, Daniel Antonio de, R. Aller, Olatz Izaola, M. González Sagrado, & R. Conde. (2005). Resting Energy Expenditure, Cardiovascular Risk Factors and Insulin Resistance in Obese Patients. Annals of Nutrition and Metabolism. 49(6). 381–385. 10 indexed citations
16.
Aller, R., et al.. (2002). Aplicación de productos liofilizados en dietas modificadas de textura en un hospital. Nutrición Hospitalaria. 17. 2 indexed citations
17.
Luis, Daniel Antonio de, et al.. (2001). Anabolic steroid and gynecomastia: Review of literature. Anales de Medicina Interna. 18(9). 45–47. 3 indexed citations
18.
Luis, Daniel Antonio de, et al.. (2001). Estado nutricional de pacientes infectados por el virus de la inmunodeficiencia humana (VIH). Anales de Medicina Interna. 18(12). 6 indexed citations
19.
Luis, Daniel Antonio de, et al.. (2001). Estudio de prevalencia de Helicobacter pylori y Chlamydia pneumoniae en placas de ateroma de pacientes diabéticos y no diabéticos con arteriosclerosis. Clínica e Investigación en Arteriosclerosis. 13(3). 103–107. 2 indexed citations
20.
Luis, Daniel Antonio de, et al.. (1999). Improvement in lipid and haemostasis patterns afterHelicobacter pylori infection eradication in type 1 diabetic patients. Clinical Nutrition. 18(4). 227–231. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Olatz Izaola Breakdown of academic impact, for papers by Bruno Geloneze Breakdown of academic impact, for papers by Teri L. Hernandez Breakdown of academic impact, for papers by Barbara M. Retzlaff Breakdown of academic impact, for papers by Bettina Mittendorfer Breakdown of academic impact, for papers by T. M. Wallace Breakdown of academic impact, for papers by Jean‐Philippe Bastard Breakdown of academic impact, for papers by Robert N. Cooney Breakdown of academic impact, for papers by Susanne Kaser Breakdown of academic impact, for papers by Priya Mohanty
Rankless by CCL
2026